Clinical Trial Update: Metformin for People With CFRD on CFTR Modulator Therapy to Improve Ion Channel Function [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating metformin for people with cystic fibrosis-related diabetes on CFTR modulator therapy to improve ion channel function; currently recruit…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cystic Fibrosis
• Cystic Fibrosis-related Diabetes

Drugs mentioned

• metformin (metformin)

Snippet

Sponsor: University of Kansas Medical Center | Conditions: Cystic Fibrosis-related Diabetes, Cystic Fibrosis | Phase 2 | Status: RECRUITING